Mammalian Target of Rapamycin Is a Therapeutic Target for Murine Ovarian Endometrioid Adenocarcinomas with Dysregulated Wnt/β-Catenin and PTEN

Pradeep S. Tanwar(Hunter Medical Research Institute), Jose M. Teixeira(Michigan State University)

PLoS ONE

June 9, 2011

10.1371/journal.pone.0020715

Cited by 48

Related Papers

Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis

|Human Molecular Genetics|2012|82

Stromal Deletion of the APC Tumor Suppressor in Mice Triggers Development of Endometrial Cancer

|Cancer Research|2011|59

Müllerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17α-Hydroxylase/C<sub>17–20</sub>Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation

|Endocrinology|2002|55

Stromal Liver Kinase B1 [STK11] Signaling Loss Induces Oviductal Adenomas and Endometrial Cancer by Activating Mammalian Target of Rapamycin Complex 1

|PLoS Genetics|2012|46

Adenomatous Polyposis Coli (APC) Is Essential for Maintaining the Integrity of the Seminiferous Epithelium

|Molecular Endocrinology|2011|46